Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
3,08,625.00
2,70,840.00
2,38,664.00
1,99,646.00
1,81,053.00
1,88,375.00
1,83,672.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,08,625.00
2,70,840.00
2,38,664.00
1,99,646.00
1,81,053.00
1,88,375.00
1,83,672.00
Raw Material Cost
1,39,161.00
1,15,906.00
1,03,532.00
85,213.00
76,095.00
75,678.00
75,350.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
949.00
196.00
247.00
248.00
145.00
125.00
148.00
Selling and Distribution Expenses
1,16,004.00
1,01,306.00
90,479.00
77,460.00
75,147.00
82,733.00
80,863.00
Other Expenses
1,404.60
1,326.50
1,086.80
853.30
779.90
695.70
676.00
Total Expenditure (Excl Depreciation)
2,70,160.00
2,30,673.00
2,05,126.00
1,71,454.00
1,59,186.00
1,65,493.00
1,63,121.00
Operating Profit (PBDIT) excl Other Income
38465
40167
33538
28192
21867
22882
20551
Other Income
6,884.00
2,465.00
2,140.00
1,216.00
4,842.00
2,214.00
-1,844.00
Operating Profit (PBDIT)
58,492.00
51,319.00
43,479.00
37,081.00
33,457.00
32,033.00
25,111.00
Interest
949.00
196.00
247.00
248.00
145.00
125.00
148.00
Exceptional Items
-2,068.00
-916.00
-1,140.00
-1,208.00
-3,558.00
-3,239.00
-2,256.00
Gross Profit (PBDT)
1,69,464.00
1,54,934.00
1,35,132.00
1,14,433.00
1,04,958.00
1,12,697.00
1,08,322.00
Depreciation
13,143.00
8,687.00
7,801.00
7,673.00
6,748.00
6,937.00
6,404.00
Profit Before Tax
42,331.00
41,518.00
34,290.00
27,953.00
23,006.00
21,730.00
16,300.00
Tax
11,379.00
10,123.00
7,860.00
6,803.00
6,236.00
6,448.00
6,481.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
31,005.00
30,937.00
26,377.00
21,019.00
16,743.00
15,409.00
9,800.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
31,005.00
30,937.00
26,377.00
21,019.00
16,743.00
15,409.00
9,800.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-54.00
457.00
52.00
131.00
27.00
-127.00
18.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30,951.00
31,394.00
26,429.00
21,150.00
16,770.00
15,282.00
9,818.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,60,095.00
2,46,326.00
2,09,570.00
1,78,289.00
1,55,908.00
1,39,283.00
1,31,272.00
Earnings per share (EPS)
135.44
135.21
115.29
91.86
73.18
67.36
42.83
Diluted Earnings per share
135.44
135.21
115.29
91.86
73.18
67.36
42.83
Operating Profit Margin (Excl OI)
12.46%
14.83%
14.05%
14.12%
12.08%
12.15%
11.19%
Gross Profit Margin
17.97%
18.54%
17.64%
17.84%
16.43%
15.22%
12.36%
PAT Margin
10.05%
11.42%
11.05%
10.53%
9.25%
8.18%
5.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 13.95% vs 13.48% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -1.41% vs 18.79% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 5.64% vs 18.18% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 384.18% vs -20.65% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Rohto Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
3,08,625.00
9,90,586.00
-6,81,961.00
-68.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,08,625.00
9,90,586.00
-6,81,961.00
-68.84%
Raw Material Cost
1,39,161.00
2,37,394.00
-98,233.00
-41.38%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
949.00
4,257.00
-3,308.00
-77.71%
Selling and Distribution Expenses
1,16,004.00
7,24,259.00
-6,08,255.00
-83.98%
Other Expenses
1,404.60
2,292.80
-888.20
-38.74%
Total Expenditure (Excl Depreciation)
2,70,160.00
9,88,838.00
-7,18,678.00
-72.68%
Operating Profit (PBDIT) excl Other Income
38,465.00
1,748.00
36,717.00
2,100.51%
Other Income
6,884.00
12,638.00
-5,754.00
-45.53%
Operating Profit (PBDIT)
58,492.00
89,196.00
-30,704.00
-34.42%
Interest
949.00
4,257.00
-3,308.00
-77.71%
Exceptional Items
-2,068.00
-12,590.00
10,522.00
83.57%
Gross Profit (PBDT)
1,69,464.00
7,53,192.00
-5,83,728.00
-77.50%
Depreciation
13,143.00
75,666.00
-62,523.00
-82.63%
Profit Before Tax
42,331.00
-3,317.00
45,648.00
1,376.18%
Tax
11,379.00
8,028.00
3,351.00
41.74%
Provisions and contingencies
0
0
0.00
Profit After Tax
31,005.00
-10,812.00
41,817.00
386.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
31,005.00
-10,812.00
41,817.00
386.76%
Share in Profit of Associates
0
0
0.00
Minority Interest
-54.00
1,518.00
-1,572.00
-103.56%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30,951.00
-9,294.00
40,245.00
433.02%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,60,095.00
6,32,474.00
-3,72,379.00
-58.88%
Earnings per share (EPS)
135.44
-27.06
162.50
600.52%
Diluted Earnings per share
135.44
-27.06
162.50
600.52%
Operating Profit Margin (Excl OI)
12.46%
0.09%
0.00
12.37%
Gross Profit Margin
17.97%
7.30%
0.00
10.67%
PAT Margin
10.05%
-1.09%
0.00
11.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 30,862.50 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 13.95% vs 13.48% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3,095.10 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -1.41% vs 18.79% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5,160.80 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 5.64% vs 18.18% in Mar 2024
Annual - Interest
Interest 94.90 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 384.18% vs -20.65% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.46%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






